Skip to main content
Premium Trial:

Request an Annual Quote

SurroMed, Lilly Launch Biomarker Partnership

NEW YORK, Sept. 3-SurroMed has launched a research collaboration with Eli Lilly to identify new biomarkers, the company said today.


Lilly will supply biological samples, which SurroMed will analyze using its mass spectrometry-based platform.


The collaboration is broad, seeking to identify biomarkers that are relevant to drug development and disease progression.


Financial details of the agreement were not revealed.


SurroMed is based in Mountain View, Calif.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.